April 2012 Drug Information Update - Pharmacy Benefits ...

More documents

Recommendations

Info

Source: www.ashp.org Valsartan Tablets March 23, 2012 Products Affected - Description Diovan tablets, Novartis 40 mg, 100 count, unit-dose (NDC 00078-0423-06) Reason for the Shortage • Novartis is the sole supplier of valsartan tablets. • Novartis could not provide a reason for the shortage. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=891 Source: www.ashp.org Trazodone Tablets March 23, 2012 Products Affected - Description Trazodone tablets, Mylan 50 mg, 100 count (NDC 00378-3471-01) - discontinued 100 mg, 100 count (NDC 00378-3472-01) - discontinued 100 mg, 1000 count (NDC 00378-3472-10) - discontinued 300 mg, 100 count (NDC 00378-3474-01) - discontinued Trazodone tablets, Qualitest 100 mg, 500 count (NDC 00603-6161-28) Reason for the Shortage • Apotex states the shortage was due to an import ban on this product that was only recently removed. Apotex relaunched trazodone tablets in September, 2011. • Mylan and Qualitest cannot provide a reason for the shortage. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=681 Source: www.ashp.org Pantoprazole Injection March 23, 2012 Products Affected - Description Protonix injection, Pfizer 40 mg vial, package of 10 (NDC 00008-0923-55) 40 mg vial, package of 25 (NDC 00008-0923-60) 40 mg Novaplus vial, package of 10 (NDC 00008-0941-04) Reason for the Shortage • Pfizer did not provide a reason for the shortage. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=895 Source: www.ashp.org Ketamine Injection March 23, 2012 Products Affected - Description Ketamine injection, Bedford 50 mg/mL, 10 mL vial, package of 10 (NDC 55390-0475-10) Ketamine injection, Hospira 58
50 mg/mL, 10 mL vial, package of 10 (NDC 00409-2053-10) Ketalar injection, JHP 10 mg/mL, 20 mL vials (NDC 42023-0113-10) Reason for the Shortage • JHP has Ketalar on shortage due to increased demand. • Mylan Institutional states the reason for the shortage is increased demand. • Hospira has ketamine on shortage due to manufacturing delays. • Ben Venue voluntarily suspended all manufacturing and distribution in mid-November, 2011. Product will become available in stages as production resumes. • Bedford Laboratories has multiple products affected by this suspension of manufacturing. Availability of all products, including those not manufactured at Ben Venue, is updated as information changes on the Bedford Laboratories website. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=592 Source: www.ashp.org Amphetamine Mixed Salts, Immediate-Release Tablets March 23, 2012 Products Affected - Description Amphetamine mixed salts immediate-release tablets, Teva 5 mg tablets, 100 count (NDC 00555-0971-02) 7.5 mg tablets, 100 count (NDC 00555-0775-02) 10 mg tablets, 100 count (NDC 00555-0972-02) 12.5 mg tablets, 100 count (NDC 00555-0776-02) 15 mg tablets, 100 count (NDC 00555-0777-02) 20 mg tablets, 100 count (NDC 00555-0973-02) 30 mg tablets, 100 count (NDC 00555-0974-02) Adderall, Teva 5 mg tablets, 100 count (NDC 00555-0762-02) 7.5 mg tablets, 100 count (NDC 00555-0763-02) 10 mg tablets, 100 count (NDC 00555-0764-02) 12.5 mg tablets, 100 count (NDC 00555-0765-02) 15 mg tablets, 100 count (NDC 00555-0766-02) 20 mg tablets, 100 count (NDC 00555-0767-02) 30 mg tablets, 100 count (NDC 00555-0764-02) Amphetamine mixed salts immediate-release tablets, Sandoz 5 mg tablets, 100 count (NDC 00185-0084-01) 10 mg tablets, 100 count (NDC 00185-0111-01) 20 mg tablets, 100 count (NDC 00185-0401-01) 30 mg tablets, 100 count (NDC 00185-0404-01) Amphetamine mixed salts immediate-release tablets, CorePharma 5 mg tablets, 100 count (NDC 64720-0130-10) 10 mg tablets, 100 count (NDC 64720-0132-10) 20 mg tablets, 100 count (NDC 64720-0135-10) 30 mg tablets, 100 count (NDC 64720-0136-10) Reason for the Shortage • Teva states the shortage is due to DEA quota restrictions. • CorePharma cannot provide a reason for the shortage. • Sandoz states the shortage is due to increased demand. 59
Page 1 and 2:
April 2012 Drug Information Update
Page 3 and 4:
First-Time Generics GENERIC DRUG NA
Page 5 and 6:
GENERAL ANESTHETICS, INJECTABLE MID
Page 7 and 8: Gruenhaupt, Mark R.Ph. Argus Health
Page 9 and 10: Statin Drugs - Drug Safety Communic
Page 11 and 12: Vytorin (ezetimibe/simvastatin) Tab
Page 13 and 14: low blood sugar (hypoglycemia) in p
Page 15 and 16: Some women with depression who beco
Page 17 and 18: Survival increased for all groups o
Page 19 and 20: finding that it also may reduce the
Page 21 and 22: Syringes (2 mL size), Rx only. NDC
Page 23 and 24: Patheon Pharmaceuticals Inc., Cinci
Page 25 and 26: 50-ct. bottles (NDC 0067-6238-50);
Page 27 and 28: PRODUCT (Class II) 1) Ventolin HFA
Page 29 and 30: Lot #: 0693, Exp: 10/2012 RECALLING
Page 31 and 32: 24 (Display case UPC# 3030045074923
Page 33 and 34: CODE Lot # 139961 RECALLING FIRM/MA
Page 35 and 36: Reason for the Shortage • Teva co
Page 37 and 38: Reason for the Shortage • Ben Ven
Page 39 and 40: Products Affected - Description Gan
Page 41 and 42: 37.5 mg/25 mg, 1000 count (NDC 0078
Page 43 and 44: Acyclovir tablets, Major 400 tablet
Page 45 and 46: 500 mg, 100 count (NDC 63304-0726-0
Page 47 and 48: 750 mg tablets, 100 count (NDC 1013
Page 49 and 50: • Bedford Laboratories has multip
Page 51 and 52: Daunorubicin Hydrochloride Injectio
Page 53 and 54: Ciprofloxacin Immediate-Release Tab
Page 55 and 56: • APP had tobramycin 40 mg/mL pre
Page 57: • Ben Venue voluntarily suspended
Page 61 and 62: 2 mL vial, preservative-free (NDC 6
Page 63 and 64: 5 mg single dose vial, package of 1
Page 65 and 66: 20 mL glass ampule, sterile pack (N
Page 67 and 68: 2 mL iSecure syringe (NDC 00406-112
Page 69 and 70: Lidocaine 0.5% Xylocaine 0.5% injec
Page 71 and 72: • Teva discontinued all ciproflox
Page 73 and 74: Nicardipine hydrochloride injection
Page 75 and 76: Article link: http://www.ashp.org/D
Page 77 and 78: • Apotex had metformin products u
Page 79: • Covis purchased all rights to F
show all

April 2012 Drug Information Update - Pharmacy Benefits ...

Create successful ePaper yourself

Delete template?

Save as template?